Last June, Keller participated in an inpatient immunotherapy trial at the National Institutes of Health\u2019s National Cancer Institute, which he said had \u201cshown great promise in potentially curing cancer.\u201d The 72-year-old is returning to the Bethesda, Maryland, facility next month to do another variation of that immunotherapy on new tumors.<\/p>\n
The tumors \u201care unfortunately in some fairly inconvenient places,\u201d Keller said, \u201cso the doctors encouraged us to go through the treatment again, this time targeting a different genetic marker of the cancer.\u201d<\/p>\n
\u201cIt was brutal last June, so we approach this with an awareness of how much prayer we need,\u201d Keller wrote on Twitter. \u201cPlease pray for our trust and dependence on God, for his providential oversight of the medical preparations now in process, and for our desire to glorify God in whatever comes our way. Thank You.\u201d<\/p>\n
Read it all<\/a>.<\/p>\n \u201cPlease pray for our trust and dependence on God, for his providential oversight of the medical preparations now in process, and for our desire to glorify God in whatever comes our way.\u201dhttps:\/\/t.co\/xhlyOxhdvA<\/a><\/p>\n — Christianity Today (@CTmagazine) March 13, 2023<\/a><\/p><\/blockquote>\n \n